Hugo_Symbol Entrez_Gene_Id Center NCBI_Build Chromosome Start_position End_position Strand Variant_Classification Variant_Type Reference_Allele Tumor_Seq_Allele1 Tumor_Seq_Allele2 dbSNP_RS dbSNP_Val_Status Tumor_Sample_Barcode Matched_Norm_Sample_Barcode Match_Norm_Seq_Allele1 Match_Norm_Seq_Allele2 Tumor_Validation_Allele1 Tumor_Validation_Allele2 Match_Norm_Validation_Allele1 Match_Norm_Validation_Allele2 Verification_Status Validation_Status Mutation_Status Sequencing_Phase Sequence_Source Validation_Method Score BAM_file Sequencer Tumor_Sample_UUID Matched_Norm_Sample_UUID Genome_Change Annotation_Transcript Transcript_Strand Transcript_Exon Transcript_Position cDNA_Change Codon_Change Protein_Change Other_Transcripts Refseq_mRNA_Id Refseq_prot_Id SwissProt_acc_Id SwissProt_entry_Id Description UniProt_AApos UniProt_Region UniProt_Site UniProt_Natural_Variations UniProt_Experimental_Info GO_Biological_Process GO_Cellular_Component GO_Molecular_Function COSMIC_overlapping_mutations COSMIC_fusion_genes COSMIC_tissue_types_affected COSMIC_total_alterations_in_gene Tumorscape_Amplification_Peaks Tumorscape_Deletion_Peaks TCGAscape_Amplification_Peaks TCGAscape_Deletion_Peaks DrugBank ref_context gc_content CCLE_ONCOMAP_overlapping_mutations CCLE_ONCOMAP_total_mutations_in_gene CGC_Mutation_Type CGC_Translocation_Partner CGC_Tumor_Types_Somatic CGC_Tumor_Types_Germline CGC_Other_Diseases DNARepairGenes_Role FamilialCancerDatabase_Syndromes MUTSIG_Published_Results OREGANNO_ID OREGANNO_Values t_alt_count t_ref_count validation_alt_allele validation_method validation_status validation_tumor_sample pox qox pox_cutoff isArtifactMode oxoGCut CYB5R2 51700 broad.mit.edu 37 11 7690411 7690411 + Missense_Mutation SNP G G A TCGA-DJ-A2Q6-01A-11D-A18F-08 TCGA-DJ-A2Q6-10A-01D-A18F-08 Untested Somatic Phase_I WXS none Illumina GAIIx e0e7f5fc-f324-4be6-b07e-02006802cd94 31720585-e4b3-43d1-8c8c-0be236e04aeb g.chr11:7690411G>A uc009yfl.1 - 3 479 c.413C>T c.(412-414)gCt>gTt p.A138V CYB5R2_uc001mfm.3_Intron|CYB5R2_uc001mfn.3_Intron|CYB5R2_uc009yfk.3_Intron Q6BCY4 NB5R2_HUMAN Homo sapiens cytochrome b5 reductase 2 (CYB5R2), mRNA. 0 sterol biosynthetic process membrane|soluble fraction cytochrome-b5 reductase activity cervix(1)|endometrium(1)|kidney(1)|large_intestine(3)|lung(3)|prostate(1)|skin(1) 11 Epithelial(150;5.48e-08)|BRCA - Breast invasive adenocarcinoma(625;0.189) CCAGCTGGGAGCCCAAGTATT 0.483000 17 48 0 0 1 0 0 GPR179 440435 broad.mit.edu 37 17 36484931 36484931 + Silent SNP T T C TCGA-DJ-A2Q6-01A-11D-A18F-08 TCGA-DJ-A2Q6-10A-01D-A18F-08 Untested Somatic Phase_I WXS none Illumina GAIIx e0e7f5fc-f324-4be6-b07e-02006802cd94 31720585-e4b3-43d1-8c8c-0be236e04aeb g.chr17:36484931T>C uc002hpz.3 - 10 4542 c.4521A>G c.(4519-4521)aaA>aaG p.K1507K NM_001004334 NP_001004334 Q6PRD1 GP179_HUMAN Homo sapiens G protein-coupled receptor 179 (GPR179), mRNA. 1507 integral to membrane|plasma membrane G-protein coupled receptor activity breast(4)|cervix(2)|endometrium(9)|kidney(3)|large_intestine(16)|lung(15)|ovary(4)|pancreas(1)|prostate(1)|stomach(2)|upper_aerodigestive_tract(2)|urinary_tract(1) 60 Breast(7;2.97e-12) Breast(25;0.0101)|Ovarian(249;0.15) TTCTGGAGGCTTTTTCCTTTT 0.483000 3 218 0 0 1 0 0 PRICKLE2 166336 broad.mit.edu 37 3 64133074 64133074 + Silent SNP C C T TCGA-DJ-A2Q6-01A-11D-A18F-08 TCGA-DJ-A2Q6-10A-01D-A18F-08 Untested Somatic Phase_I WXS none Illumina GAIIx e0e7f5fc-f324-4be6-b07e-02006802cd94 31720585-e4b3-43d1-8c8c-0be236e04aeb g.chr3:64133074C>T uc003dmf.3 - 6 1678 c.1092G>A c.(1090-1092)cgG>cgA p.R364R NM_198859 NP_942559 Q7Z3G6 PRIC2_HUMAN Homo sapiens prickle homolog 2 (Drosophila) (PRICKLE2), mRNA. 364 cytoplasm|nuclear membrane zinc ion binding breast(2)|endometrium(1)|large_intestine(9)|liver(1)|lung(10)|ovary(4)|prostate(2)|skin(2)|stomach(1) 32 Lung NSC(201;0.136) BRCA - Breast invasive adenocarcinoma(55;0.000971)|KIRC - Kidney renal clear cell carcinoma(15;0.00443)|Kidney(15;0.00497) CGGCTGACAGCCGGTTAGAAC 0.617000 5 137 0 0 1 0 0 ITM2C 81618 broad.mit.edu 37 2 231740375 231740375 + Missense_Mutation SNP A A G TCGA-DJ-A2Q6-01A-11D-A18F-08 TCGA-DJ-A2Q6-10A-01D-A18F-08 Untested Somatic Phase_I WXS none Illumina GAIIx e0e7f5fc-f324-4be6-b07e-02006802cd94 31720585-e4b3-43d1-8c8c-0be236e04aeb g.chr2:231740375A>G uc002vqz.3 + 2 422 c.302A>G c.(301-303)gAg>gGg p.E101G ITM2C_uc002vra.3_Missense_Mutation_p.E54G|ITM2C_uc002vrb.3_Missense_Mutation_p.E101G|ITM2C_uc002vrc.3_5'UTR|ITM2C_uc002vrd.3_5'UTR NM_030926 NP_112188 Q9NQX7 ITM2C_HUMAN Homo sapiens integral membrane protein 2C (ITM2C), transcript variant 1, mRNA. 101 negative regulation of neuron projection development|neuron differentiation Golgi apparatus|integral to membrane|lysosomal membrane|perinuclear region of cytoplasm beta-amyloid binding cervix(2)|lung(1)|ovary(1)|skin(1) 5 Renal(207;0.0112)|all_lung(227;0.0741)|all_hematologic(139;0.0748)|Acute lymphoblastic leukemia(138;0.167)|Lung NSC(271;0.204) Epithelial(121;8.47e-12)|all cancers(144;3.44e-09)|LUSC - Lung squamous cell carcinoma(224;0.0115)|Lung(119;0.0142) GTGCTGTATGAGGACTCCCTG 0.567000 3 170 0 0 1 0 0 MARCH6 10299 broad.mit.edu 37 5 10414577 10414577 + Silent SNP A A G TCGA-DJ-A2Q6-01A-11D-A18F-08 TCGA-DJ-A2Q6-10A-01D-A18F-08 Untested Somatic Phase_I WXS none Illumina GAIIx e0e7f5fc-f324-4be6-b07e-02006802cd94 31720585-e4b3-43d1-8c8c-0be236e04aeb g.chr5:10414577A>G uc003jet.1 + 19 2112 c.1929A>G c.(1927-1929)acA>acG p.T643T MARCH6_uc011cmu.1_Silent_p.T595T|MARCH6_uc003jeu.1_Silent_p.T341T|MARCH6_uc011cmv.1_Silent_p.T538T NM_005885 NP_005876 O60337 MARH6_HUMAN Homo sapiens membrane-associated ring finger (C3HC4) 6 (MARCH6), mRNA. 643 protein K48-linked ubiquitination integral to endoplasmic reticulum membrane ubiquitin conjugating enzyme binding|ubiquitin-protein ligase activity|zinc ion binding breast(1)|cervix(1)|endometrium(3)|kidney(3)|large_intestine(7)|lung(35)|ovary(1)|urinary_tract(3) 54 TGTGTATAACATTACTGATTG 0.348000 4 82 0 0 1 0 0 MEOX1 4222 broad.mit.edu 37 17 41738500 41738500 + Missense_Mutation SNP C C A TCGA-DJ-A2Q6-01A-11D-A18F-08 TCGA-DJ-A2Q6-10A-01D-A18F-08 Untested Somatic Phase_I WXS none Illumina GAIIx e0e7f5fc-f324-4be6-b07e-02006802cd94 31720585-e4b3-43d1-8c8c-0be236e04aeb g.chr17:41738500C>A uc002idz.3 - 0 432 c.403G>T c.(403-405)Ggg>Tgg p.G135W MEOX1_uc002iea.3_Missense_Mutation_p.G135W|MEOX1_uc002ieb.3_Missense_Mutation_p.G20W NM_004527 NP_001035091 P50221 MEOX1_HUMAN Homo sapiens mesenchyme homeobox 1 (MEOX1), transcript variant 1, mRNA. 135 nucleus sequence-specific DNA binding p.G135W(2) NS(1)|endometrium(1)|kidney(1)|large_intestine(1)|lung(4) 8 Breast(137;0.00908) BRCA - Breast invasive adenocarcinoma(366;0.0753) CCAAGCACCCCGTAGTCATCG 0.607000 4 178 0 0 1 0 0 BRAF 673 broad.mit.edu 37 7 140453136 140453136 + Missense_Mutation SNP A A T rs121913377 TCGA-DJ-A2Q6-01A-11D-A18F-08 TCGA-DJ-A2Q6-10A-01D-A18F-08 Untested Somatic Phase_I WXS none Illumina GAIIx e0e7f5fc-f324-4be6-b07e-02006802cd94 31720585-e4b3-43d1-8c8c-0be236e04aeb g.chr7:140453136A>T uc003vwc.4 - 14 1860 c.1799T>A c.(1798-1800)gTg>gAg p.V600E NM_004333 NP_004324 P15056 BRAF_HUMAN Homo sapiens v-raf murine sarcoma viral oncogene homolog B1 (BRAF), mRNA. 600 Protein kinase. V -> D (in a melanoma cell line; requires 2 nucleotide substitutions).|V -> E (in sarcoma, colorectal adenocarcinoma, metastatic melanoma, ovarian serous carcinoma, pilocytic astrocytoma; somatic mutation; most common mutation; constitutive and elevated kinase activity; efficiently induces cell transformation; suppression of mutation in melanoma causes growth arrest and promotes apoptosis). activation of MAPKK activity|anti-apoptosis|nerve growth factor receptor signaling pathway|organ morphogenesis|positive regulation of peptidyl-serine phosphorylation|small GTPase mediated signal transduction|synaptic transmission cytosol|nucleus|plasma membrane ATP binding|metal ion binding p.V600E(41204)|p.V600K(615)|p.V600?(377)|p.V600R(99)|p.V600D(40)|p.V600_K601>E(30)|p.V600L(28)|p.V600A(24)|p.V600G(22)|p.V600M(22)|p.A598_T599insV(7)|p.T599_V600insT(7)|p.T599I(5)|p.V600Q(4)|p.T599_R603>I(4)|p.T599_V600insTT(3)|p.T599_V600insDFGLAT(2)|p.T599_V600>IAL(2)|p.V600_S605>EK(2)|p.T599T(2)|p.V600_S605>DV(2)|p.V600_S605>D(2)|p.V600_W604del(1)|p.V600V(1)|p.T599_V600insV(1)|p.V600>DLAT(1)|p.D594_T599del(1) SLC45A3/BRAF(2)|AGTRAP/BRAF(2)|FAM131B_ENST00000443739/BRAF(7)|AKAP9_ENST00000356239/BRAF(10)|KIAA1549/BRAF(703)|FCHSD1/BRAF(2) NS(588)|adrenal_gland(3)|autonomic_ganglia(3)|biliary_tract(29)|bone(7)|breast(21)|central_nervous_system(99)|cervix(6)|endometrium(33)|eye(72)|gastrointestinal_tract_(site_indeterminate)(2)|genital_tract(4)|haematopoietic_and_lymphoid_tissue(436)|kidney(3)|large_intestine(6953)|liver(17)|lung(192)|oesophagus(4)|ovary(275)|pancreas(15)|pituitary(1)|prostate(25)|salivary_gland(1)|skin(6285)|small_intestine(12)|soft_tissue(40)|stomach(11)|testis(7)|thyroid(12220)|upper_aerodigestive_tract(13)|urinary_tract(3) 27380 Melanoma(164;0.00956) Sorafenib(DB00398) TCGAGATTTCACTGTAGCTAG 0.368000 V600D(K029AX_SKIN)|V600D(WM115_SKIN)|V600D(WM2664_SKIN)|V600E(8505C_THYROID)|V600E(A101D_SKIN)|V600E(A2058_SKIN)|V600E(A375_SKIN)|V600E(A673_BONE)|V600E(AM38_CENTRAL_NERVOUS_SYSTEM)|V600E(BCPAP_THYROID)|V600E(BHT101_THYROID)|V600E(BT474_BREAST)|V600E(C32_SKIN)|V600E(CL34_LARGE_INTESTINE)|V600E(COLO205_LARGE_INTESTINE)|V600E(COLO679_SKIN)|V600E(COLO741_SKIN)|V600E(COLO783_SKIN)|V600E(COLO800_SKIN)|V600E(COLO818_SKIN)|V600E(COLO829_SKIN)|V600E(COLO849_SKIN)|V600E(DBTRG05MG_CENTRAL_NERVOUS_SYSTEM)|V600E(DU4475_BREAST)|V600E(ES2_OVARY)|V600E(G361_SKIN)|V600E(GCT_SOFT_TISSUE)|V600E(HS294T_SKIN)|V600E(HS695T_SKIN)|V600E(HS939T_SKIN)|V600E(IGR1_SKIN)|V600E(IGR37_SKIN)|V600E(IGR39_SKIN)|V600E(K029AX_SKIN)|V600E(KG1C_CENTRAL_NERVOUS_SYSTEM)|V600E(LOXIMVI_SKIN)|V600E(MALME3M_SKIN)|V600E(MELHO_SKIN)|V600E(OUMS23_LARGE_INTESTINE)|V600E(RKO_LARGE_INTESTINE)|V600E(RPMI7951_SKIN)|V600E(RVH421_SKIN)|V600E(SH4_SKIN)|V600E(SIGM5_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE)|V600E(SKHEP1_LIVER)|V600E(SKMEL24_SKIN)|V600E(SKMEL28_SKIN)|V600E(SKMEL5_SKIN)|V600E(SW1417_LARGE_INTESTINE)|V600E(UACC257_SKIN)|V600E(UACC62_SKIN)|V600E(WM793_SKIN)|V600E(WM88_SKIN)|V600E(WM983B_SKIN) 61 """Mis, T, O""" """AKAP9, KIAA1549""" """melanoma, colorectal, papillary thyroid, borderline ov, Non small-cell lung cancer (NSCLC), cholangiocarcinoma, pilocytic astrocytoma""" Cardio-facio-cutaneous syndrome Cardiofaciocutaneous syndrome 27 45 0 0 1 0 0 AHNAK 79026 broad.mit.edu 37 11 62294421 62294421 + Missense_Mutation SNP T T C TCGA-DJ-A2Q6-01A-11D-A18F-08 TCGA-DJ-A2Q6-10A-01D-A18F-08 Untested Somatic Phase_I WXS none Illumina GAIIx e0e7f5fc-f324-4be6-b07e-02006802cd94 31720585-e4b3-43d1-8c8c-0be236e04aeb g.chr11:62294421T>C uc001ntl.3 - 4 7768 c.7468A>G c.(7468-7470)Agg>Ggg p.R2490G AHNAK_uc001ntk.1_Intron NM_001620 NP_001611 Q09666 AHNK_HUMAN Homo sapiens AHNAK nucleoprotein (AHNAK), transcript variant 1, mRNA. 2490 nervous system development nucleus protein binding NS(3)|autonomic_ganglia(1)|breast(10)|central_nervous_system(5)|endometrium(17)|haematopoietic_and_lymphoid_tissue(2)|kidney(33)|large_intestine(40)|liver(1)|lung(108)|ovary(13)|pancreas(4)|prostate(5)|skin(16)|stomach(2)|upper_aerodigestive_tract(2)|urinary_tract(6) 268 Melanoma(852;0.155) TTGGGGCCCCTGATGTTCATA 0.478000 4 209 0 0 1 0 0 CACNB3 784 broad.mit.edu 37 12 49218501 49218501 + Missense_Mutation SNP C C G TCGA-DJ-A2Q6-01A-11D-A18F-08 TCGA-DJ-A2Q6-10A-01D-A18F-08 Untested Somatic Phase_I WXS none Illumina GAIIx e0e7f5fc-f324-4be6-b07e-02006802cd94 31720585-e4b3-43d1-8c8c-0be236e04aeb g.chr12:49218501C>G uc001rsl.2 + 4 916 c.457C>G c.(457-459)Cct>Gct p.P153A CACNB3_uc010slx.2_Missense_Mutation_p.P140A|CACNB3_uc010sly.2_Missense_Mutation_p.P140A|CACNB3_uc010slz.2_Missense_Mutation_p.P152A|CACNB3_uc001rsk.2_5'UTR|CACNB3_uc021qxm.1_Missense_Mutation_p.P112A NM_000725 NP_000716 P54284 CACB3_HUMAN Homo sapiens calcium channel, voltage-dependent, beta 3 subunit (CACNB3), transcript variant 1, mRNA. 153 axon guidance|membrane depolarization|synaptic transmission cytosol|voltage-gated calcium channel complex protein binding|voltage-gated calcium channel activity autonomic_ganglia(1)|breast(1)|large_intestine(5)|lung(4)|prostate(1) 12 Verapamil(DB00661) CCGACGCTCCCCTCCGCCATC 0.547000 3 68 0 0 1 0 0 CYP2C9 1559 broad.mit.edu 37 10 96701709 96701709 + Missense_Mutation SNP T T C rs139656048 TCGA-DJ-A2Q6-01A-11D-A18F-08 TCGA-DJ-A2Q6-10A-01D-A18F-08 Untested Somatic Phase_I WXS none Illumina GAIIx e0e7f5fc-f324-4be6-b07e-02006802cd94 31720585-e4b3-43d1-8c8c-0be236e04aeb g.chr10:96701709T>C uc001kka.4 + 1 288 c.263T>C c.(262-264)aTt>aCt p.I88T CYP2C9_uc009xut.3_Missense_Mutation_p.I88T|CYP2C9_uc001kjz.3_Missense_Mutation_p.I88T NM_000771 NP_000762 P11712 CP2C9_HUMAN Homo sapiens cytochrome P450, family 2, subfamily C, polypeptide 9 (CYP2C9), mRNA. 88 exogenous drug catabolic process|monocarboxylic acid metabolic process|monoterpenoid metabolic process|oxidative demethylation|steroid metabolic process|urea metabolic process|xenobiotic metabolic process endoplasmic reticulum membrane|microsome (S)-limonene 6-monooxygenase activity|(S)-limonene 7-monooxygenase activity|4-hydroxyacetophenone monooxygenase activity|caffeine oxidase activity|drug binding|electron carrier activity|heme binding|oxygen binding|steroid hydroxylase activity breast(2)|cervix(1)|endometrium(1)|kidney(1)|large_intestine(8)|lung(9)|ovary(2)|prostate(1)|skin(6)|upper_aerodigestive_tract(2)|urinary_tract(1) 34 Colorectal(252;0.0902) all cancers(201;6.93e-05) Acenocoumarol(DB01418)|Alosetron(DB00969)|Amiodarone(DB01118)|Antihemophilic Factor(DB00025)|Aprepitant(DB00673)|Bosentan(DB00559)|Carprofen(DB00821)|Carvedilol(DB01136)|Celecoxib(DB00482)|Clomipramine(DB01242)|Dapsone(DB00250)|Delavirdine(DB00705)|Desloratadine(DB00967)|Desogestrel(DB00304)|Diclofenac(DB00586)|Esomeprazole(DB00736)|Etodolac(DB00749)|Fluconazole(DB00196)|Fluoxetine(DB00472)|Flurbiprofen(DB00712)|Fluvastatin(DB01095)|Fluvoxamine(DB00176)|Formoterol(DB00983)|Gemfibrozil(DB01241)|Ginkgo biloba(DB01381)|Glibenclamide(DB01016)|Glimepiride(DB00222)|Glipizide(DB01067)|Guanfacine(DB01018)|Hydromorphone(DB00327)|Ibuprofen(DB01050)|Imipramine(DB00458)|Irbesartan(DB01029)|Ketoconazole(DB01026)|Lansoprazole(DB00448)|Losartan(DB00678)|Lumiracoxib(DB01283)|Marinol(DB00470)|Mefenamic acid(DB00784)|Meloxicam(DB00814)|Mephenytoin(DB00532)|Metronidazole(DB00916)|Miconazole(DB01110)|Midazolam(DB00683)|Montelukast(DB00471)|Nateglinide(DB00731)|Nelfinavir(DB00220)|Nicardipine(DB00622)|Oxymorphone(DB01192)|Pantoprazole(DB00213)|Paramethadione(DB00617)|Phenprocoumon(DB00946)|Phenytoin(DB00252)|Pravastatin(DB00175)|Quinidine(DB00908)|Ritonavir(DB00503)|Rosiglitazone(DB00412)|Sertraline(DB01104)|Sildenafil(DB00203)|Sulfamethoxazole(DB01015)|Suprofen(DB00870)|Tamoxifen(DB00675)|Tenoxicam(DB00469)|Terfenadine(DB00342)|Tolbutamide(DB01124)|Torasemide(DB00214)|Troleandomycin(DB01361)|Valdecoxib(DB00580)|Valsartan(DB00177)|Voriconazole(DB00582)|Warfarin(DB00682)|Zafirlukast(DB00549)|Zileuton(DB00744) GAAGCCCTGATTGATCTTGGA 0.478000 13 158 0 0 1 0 0 CELF2 10659 broad.mit.edu 37 10 11370890 11370890 + Splice_Site SNP T T C TCGA-DJ-A2Q6-01A-11D-A18F-08 TCGA-DJ-A2Q6-10A-01D-A18F-08 Untested Somatic Phase_I WXS none Illumina GAIIx e0e7f5fc-f324-4be6-b07e-02006802cd94 31720585-e4b3-43d1-8c8c-0be236e04aeb g.chr10:11370890T>C uc001ikk.2 + 14 1635 c.1475_splice c.e14-1 p.G492_splice CELF2_uc010qbj.1_Splice_Site_p.G473_splice|CELF2_uc001iki.4_Splice_Site_p.G467_splice|CELF2_uc001ikl.4_Splice_Site_p.G480_splice|CELF2_uc010qbl.1_Splice_Site_p.G443_splice|CELF2_uc010qbm.1_Splice_Site_p.G239_splice|CELF2_uc001iko.4_Splice_Site_p.G447_splice|CELF2_uc001ikp.4_Splice_Site_p.G449_splice|CELF2_uc010qbo.1_Splice_Site_p.G362_splice|CELF2_uc010qbp.1_Splice_Site_p.G239_splice NM_001083591 NP_001077060 O95319 CELF2_HUMAN Homo sapiens CUGBP, Elav-like family member 2 (CELF2), transcript variant 4, mRNA. 467 Necessary for RNA-binding, TNNT2 exon 5 and NMDA R1 exon 21 inclusion.|RRM 3. mRNA processing|regulation of heart contraction cytoplasm|nucleus RNA binding|nucleotide binding|protein binding breast(2)|central_nervous_system(1)|endometrium(4)|large_intestine(2)|lung(5)|prostate(1)|skin(1) 16 ATTTTCCAGGTTTTGTTAGCT 0.517000 3 96 0 0 1 0 0 ZNF804A 91752 broad.mit.edu 37 2 185802431 185802431 + Nonsense_Mutation SNP C C T TCGA-DJ-A2Q6-01A-11D-A18F-08 TCGA-DJ-A2Q6-10A-01D-A18F-08 Untested Somatic Phase_I WXS none Illumina GAIIx e0e7f5fc-f324-4be6-b07e-02006802cd94 31720585-e4b3-43d1-8c8c-0be236e04aeb g.chr2:185802431C>T uc002uph.3 + 3 2902 c.2308C>T c.(2308-2310)Cga>Tga p.R770* NM_194250 NP_919226 Q7Z570 Z804A_HUMAN Homo sapiens zinc finger protein 804A (ZNF804A), mRNA. 770 intracellular zinc ion binding p.R770Q(2)|p.R770*(2) NS(5)|breast(2)|endometrium(5)|haematopoietic_and_lymphoid_tissue(1)|kidney(7)|large_intestine(22)|liver(2)|lung(79)|ovary(7)|pancreas(1)|prostate(2)|skin(12)|urinary_tract(1) 146 AAGATTCTATCGAAAACGTAG 0.338000 16 66 0 0 1 0 0 SULF2 55959 broad.mit.edu 37 20 46313295 46313295 + Silent SNP C C T TCGA-DJ-A2Q6-01A-11D-A18F-08 TCGA-DJ-A2Q6-10A-01D-A18F-08 Untested Somatic Phase_I WXS none Illumina GAIIx e0e7f5fc-f324-4be6-b07e-02006802cd94 31720585-e4b3-43d1-8c8c-0be236e04aeb g.chr20:46313295C>T uc002xto.3 - 5 1098 c.768G>A c.(766-768)ccG>ccA p.P256P SULF2_uc002xtr.3_Silent_p.P256P|SULF2_uc002xtq.3_Silent_p.P256P NM_018837 NP_061325 Q8IWU5 SULF2_HUMAN Homo sapiens sulfatase 2 (SULF2), transcript variant 1, mRNA. 256 bone development|heparan sulfate proteoglycan metabolic process|kidney development|negative regulation of fibroblast growth factor receptor signaling pathway Golgi stack|cell surface|endoplasmic reticulum|extracellular space arylsulfatase activity|calcium ion binding p.P256L(1) breast(2)|endometrium(4)|kidney(1)|large_intestine(7)|lung(22)|ovary(4)|pancreas(1)|prostate(5)|skin(5)|upper_aerodigestive_tract(2)|urinary_tract(1) 54 AGTGTTTGTCCGGGTTGGGCG 0.617000 3 34 0 0 1 0 0 OR4D5 219875 broad.mit.edu 37 11 123811251 123811251 + Missense_Mutation SNP G G T rs143337717 TCGA-DJ-A2Q6-01A-11D-A18F-08 TCGA-DJ-A2Q6-10A-01D-A18F-08 Untested Somatic Phase_I WXS none Illumina GAIIx e0e7f5fc-f324-4be6-b07e-02006802cd94 31720585-e4b3-43d1-8c8c-0be236e04aeb g.chr11:123811251G>T uc001pzk.1 + 0 928 c.928G>T c.(928-930)Ggt>Tgt p.G310C NM_001001965 NP_001001965 Q8NGN0 OR4D5_HUMAN Homo sapiens olfactory receptor, family 4, subfamily D, member 5 (OR4D5), mRNA. 310 sensory perception of smell integral to membrane|plasma membrane olfactory receptor activity autonomic_ganglia(1)|endometrium(2)|kidney(2)|large_intestine(4)|lung(17)|ovary(1)|pancreas(1)|prostate(7)|skin(3)|stomach(1)|upper_aerodigestive_tract(1)|urinary_tract(1) 41 Breast(109;0.00867)|Medulloblastoma(222;0.0523)|Lung NSC(97;0.118)|all_lung(97;0.126)|all_neural(223;0.22) BRCA - Breast invasive adenocarcinoma(274;4.88e-06)|OV - Ovarian serous cystadenocarcinoma(99;0.0399) GGACCCTATTGGTCCCCTGGA 0.502000 24 43 0 0 1 0 0 FAM22F 54754 broad.mit.edu 37 9 97084601 97084601 + Nonsense_Mutation SNP G G A TCGA-DJ-A2Q6-01A-11D-A18F-08 TCGA-DJ-A2Q6-10A-01D-A18F-08 Untested Somatic Phase_I WXS none Illumina GAIIx e0e7f5fc-f324-4be6-b07e-02006802cd94 31720585-e4b3-43d1-8c8c-0be236e04aeb g.chr9:97084601G>A uc004aup.1 - 2 745 c.724C>T c.(724-726)Cga>Tga p.R242* NM_017561 NP_060031 A1L443 FA22F_HUMAN Homo sapiens family with sequence similarity 22, member F (FAM22F), mRNA. 242 central_nervous_system(1)|endometrium(1)|large_intestine(10)|lung(2)|prostate(2)|skin(2)|urinary_tract(1) 19 Acute lymphoblastic leukemia(62;0.136) GCCAGGGATCGGAGAACTGGG 0.632000 4 41 0 0 1 0 0